| Primary |
| Hyperlipidaemia |
17.0% |
| Hypertension |
16.6% |
| Hypercholesterolaemia |
9.5% |
| Dyslipidaemia |
8.8% |
| Blood Cholesterol Increased |
7.3% |
| Cardiovascular Event Prophylaxis |
6.5% |
| Coronary Artery Disease |
5.2% |
| Diabetes Mellitus |
3.5% |
| Thrombosis Prophylaxis |
3.3% |
| Prophylaxis |
3.0% |
| Supplementation Therapy |
2.7% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Back Pain |
2.2% |
| Benign Prostatic Hyperplasia |
2.0% |
| Cardiac Failure |
1.8% |
| Myocardial Ischaemia |
1.8% |
| Angina Pectoris |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Medical Diet |
1.6% |
| Acute Coronary Syndrome |
1.4% |
|
| Rhabdomyolysis |
23.4% |
| Myalgia |
21.4% |
| Renal Failure Acute |
10.9% |
| Bladder Cancer |
4.0% |
| Myasthenia Gravis |
4.0% |
| Pain In Extremity |
3.5% |
| Vomiting |
3.5% |
| Pancreatitis Acute |
3.0% |
| Amyotrophic Lateral Sclerosis |
2.5% |
| Haematuria |
2.5% |
| Hepatic Function Abnormal |
2.5% |
| Liver Function Test Abnormal |
2.5% |
| Tremor |
2.5% |
| Confusional State |
2.0% |
| Cryptogenic Organising Pneumonia |
2.0% |
| Demyelinating Polyneuropathy |
2.0% |
| Interstitial Lung Disease |
2.0% |
| Myelodysplastic Syndrome |
2.0% |
| Renal Cell Carcinoma |
2.0% |
| Syncope |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
40.7% |
| Blood Cholesterol Increased |
11.6% |
| Hypertension |
10.5% |
| Hypercholesterolaemia |
6.2% |
| Hyperlipidaemia |
4.9% |
| Drug Use For Unknown Indication |
4.3% |
| Diabetes Mellitus |
2.9% |
| Dyslipidaemia |
2.9% |
| Coronary Artery Disease |
1.9% |
| Type 2 Diabetes Mellitus |
1.7% |
| Supplementation Therapy |
1.6% |
| Systemic Lupus Erythematosus |
1.6% |
| Pain |
1.5% |
| Back Pain |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Blood Cholesterol |
1.1% |
| Thrombosis Prophylaxis |
1.1% |
| Cardiac Failure |
1.0% |
| Cardiovascular Event Prophylaxis |
1.0% |
| Type Iia Hyperlipidaemia |
1.0% |
|
| Completed Suicide |
10.5% |
| Rhabdomyolysis |
8.8% |
| Myalgia |
7.6% |
| Weight Decreased |
7.0% |
| Angioedema |
6.4% |
| Sleep Disorder |
6.4% |
| Toxicity To Various Agents |
6.4% |
| Nausea |
5.8% |
| Blood Bilirubin Increased |
4.7% |
| Hypersensitivity |
4.1% |
| Malaise |
4.1% |
| Cardio-respiratory Arrest |
3.5% |
| Polyneuropathy |
3.5% |
| Renal Failure Acute |
3.5% |
| Respiratory Arrest |
3.5% |
| Tachycardia |
3.5% |
| Intentional Overdose |
2.9% |
| Serum Ferritin Increased |
2.9% |
| Blood Creatine Phosphokinase Increased |
2.3% |
| Demyelinating Polyneuropathy |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.3% |
| Drug Use For Unknown Indication |
26.0% |
| Hypertension |
8.7% |
| Rheumatoid Arthritis |
4.2% |
| Diabetes Mellitus |
4.0% |
| Blood Cholesterol Increased |
3.1% |
| Type 2 Diabetes Mellitus |
3.0% |
| Atrial Fibrillation |
2.6% |
| Pain |
2.1% |
| Prophylaxis |
1.9% |
| Hiv Infection |
1.8% |
| Cardiac Disorder |
1.7% |
| Hypercholesterolaemia |
1.6% |
| Depression |
1.6% |
| Coronary Artery Disease |
1.6% |
| Blood Cholesterol |
1.5% |
| Blood Pressure |
1.2% |
| Osteoporosis |
1.1% |
| Myocardial Ischaemia |
1.0% |
| Acute Myocardial Infarction |
1.0% |
|
| Vomiting |
8.7% |
| Weight Decreased |
8.0% |
| Flushing |
7.1% |
| Pruritus |
6.1% |
| Myalgia |
5.9% |
| Myocardial Infarction |
5.9% |
| Renal Failure Acute |
5.7% |
| Sepsis |
5.5% |
| Syncope |
5.2% |
| Nausea |
4.7% |
| Death |
4.5% |
| Rash |
4.0% |
| Blood Glucose Increased |
3.8% |
| High Density Lipoprotein Decreased |
3.8% |
| Hypotension |
3.8% |
| Weight Increased |
3.8% |
| Pyrexia |
3.5% |
| Tremor |
3.5% |
| Malaise |
3.3% |
| Pneumonia |
3.3% |
|
| Interacting |
| Hypercholesterolaemia |
15.7% |
| Hiv Infection |
14.6% |
| Immunosuppression |
9.7% |
| Hypertriglyceridaemia |
8.6% |
| Product Used For Unknown Indication |
7.0% |
| Chest Pain |
6.5% |
| Liver Transplant |
6.5% |
| Depression |
5.4% |
| Drug Use For Unknown Indication |
5.4% |
| Dyslipidaemia |
5.4% |
| Antiretroviral Therapy |
3.2% |
| Renal Impairment |
2.2% |
| Dementia |
1.6% |
| Urinary Tract Infection |
1.6% |
| Atrial Fibrillation |
1.1% |
| Dementia Alzheimer's Type |
1.1% |
| Diabetes Mellitus |
1.1% |
| Erectile Dysfunction |
1.1% |
| Hypertension |
1.1% |
| Low Density Lipoprotein Increased |
1.1% |
|
| Drug Interaction |
32.5% |
| Rhabdomyolysis |
25.0% |
| Asthenia |
7.5% |
| Delirium |
7.5% |
| Dyslipidaemia |
7.5% |
| Transaminases Increased |
5.0% |
| Blood Lactate Dehydrogenase Increased |
2.5% |
| Hypochromic Anaemia |
2.5% |
| International Normalised Ratio Increased |
2.5% |
| Oedema Peripheral |
2.5% |
| Renal Impairment |
2.5% |
| Therapeutic Product Ineffective |
2.5% |
|
